Study: Oral Cancer May Be Costliest to Treat
Oral cavity, oral pharyngeal and salivary gland cancers may be the costliest cancers to treat in the United States, according to a study in Head & Neck Oncology.
Researchers studied cost data for OC/OP/SG cancer patients compared with costs for patients without this type of cancer. They found total annual healthcare spending for OC/OP/SG patients with commercial insurance one year after diagnosis was $79,151 compared with $7,419 for people without OC/OP/SG cancer, indicating the cost burden of oral cancer was $71,732 for these patients. The cost burden was $35,890 for Medicare patients and $44,541 for Medicaid patients.
The authors suggested the cost of treatment for OC/OP/SG cancer may be the highest compared with costs for other cancers, which range from $31,559 to $65,123, according to other studies the authors cited.
More Articles on Cancer Costs:Medical Oncologists' Reimbursement Incentivizes Choosing High-Cost Meds
Study: Cancer Patients' Higher Survival in U.S. vs. Europe "Worth" the Extra Costs
Study: Chemotherapy Patient Care Costs 24% More in Hospital Outpatient Setting Than in Physician Office
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.